LeserbriefKommentar
Serum albumin in cancer survivors with heart failure: beyond a static prognostic marker
Heart and Vessels · 05.04.2026
DOI: 10.1007/s00380-026-02681-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Heart and Vessels, online erschienen am 05.04.2026. Verfasst von Hao Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310000, China. Die Arbeit nennt 4 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310000, China.
- Department of Cardiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310000, China.
- Department of Cardiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310000, China. xyzhzsyxnk@163.com.
Zitieren
APA
Chen, H., & Xu, Y. (2026). Serum albumin in cancer survivors with heart failure: beyond a static prognostic marker. Heart and Vessels. https://doi.org/10.1007/s00380-026-02681-4
Vancouver
Chen H, Xu Y. Serum albumin in cancer survivors with heart failure: beyond a static prognostic marker. Heart and Vessels. 2026. doi:10.1007/s00380-026-02681-4
BibTeX
@article{Chen2026,
author = {Chen, Hao and Xu, Yizhou},
title = {Serum albumin in cancer survivors with heart failure: beyond a static prognostic marker},
journal = {Heart and Vessels},
year = {2026},
doi = {10.1007/s00380-026-02681-4}
}
EUVIMED